Generative AI and other technologies are transforming clinical research and trials. Find out how it's done. The clinical trials sector is risk-averse, heavily regulated, and not often thought of as a technology first-mover. How is Merck changing that perception by using AI to improve insights, innovation, and operations? Join Steve Odland and guest Jennifer Sheller, senior vice president and head of global clinical trial operations at Merck, to find out how the company is using AI for clinical research and clinical trials, why "human in the loop" remains essential, and how <span class= "NormalTextRun SCXW20605204
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from C-Suite Perspectives
How CHROs Create People-First, Performance-Driven Companies
Europe's CEOs on Economic Outlook, Business Prospects, and Risks
America at 250: How Can We Move Past Political Deadlock?
Building Investor Trust Through Sustainable Finance
Get summaries like this every morning.
Free AI-powered recaps of C-Suite Perspectives and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.